RWA WEALTH PARTNERS, LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1544576 BOSTON, MA

Position in CRNX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$346,920

+$10,198 QoQ

Shares Held

9,271

0.0% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#166

of 264 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RWA WEALTH PARTNERS, LLC holds $2,823,823 across 5 Biotechnology names. CRNX ranks #3 (12.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,714	$1,348,124
2	EXEL	Exelixis, Inc.	8,806	$479,134
3	CRNX	Crinetics Pharmaceuticals, Inc. This page	9,271	$346,920
4	BHVN	Biohaven Ltd.	23,000	$342,240
5	REGN	Regeneron Pharmaceuticals, Inc.	493	$307,405

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$346,920	9,271	0.0%	Shares	Sole	2026-08-07
2026-03-31	$336,722	9,271	+35.4%	Shares	Sole	2026-05-13
2025-12-31	$318,681	6,846	+20.2%	Shares	Sole	2026-02-12
2025-09-30	$237,238	5,696	0.0%	Shares	Sole	2025-11-10
2024-12-31	$291,236	5,696	0.0%	Shares	Sole	2025-02-12
2024-09-30	$291,065	5,696	0.0%	Shares	Sole	2024-11-08
2024-06-30	$255,123	5,696	0.0%	Shares	Sole	2024-08-12
2024-03-31	$266,629	5,696	0.0%	Shares	Sole	2024-04-29
2023-12-31	$202,663	5,696	—	Shares	Sole	2024-02-01
No filing history on record for this holder in this stock.